findmyKOL

Laxmi Mehta, MD

Basic profile

The Ohio State University Wexner Medical Center

ORCID↗NPI↗
✓ Full record
RegionColumbus, OH · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Laxmi Mehta is a Cardiology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 629 publications with 7,850 citations (h-index 39).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
629publications

Distinct works indexed by OpenAlex, matched via ORCID.

7,850citations

Total citations across indexed works.

39h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1800 Zollinger Rd Fl 2
Columbus, OH 432212800

Telephone

614-293-7677

Provider last certified this registry record 20 Apr 2026.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    93.6%
    Statin29%
    Rosuvastatin Calcium63%Atorvastatin Calcium33%Pravastatin Sodium4%
    Part D≥135 patients
    PCSK9 Inhibitor14.1%
    Repatha Sureclick60%Praluent Pen40%
    Part D≥41 patients

    + 14 more classes in this area

  • Blood & clotting

    5.2%
    Factor Xa inhibitor3.3%
    Eliquis100%
    Part D≥23 patients
    P2Y12 inhibitor1.3%
    Clopidogrel100%
    Part D≥11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    1.3%
    Potassium supplement1.3%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)48.9% facility · 51.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”